Rarecells unveils new clinical data highlighting enhanced sensitivity in early-stage lung cancer detection
Synergistic combination of ctDNA and ISET CTC-DNA improves tumor heterogeneity analysis and diagnostic accuracy
Synergistic combination of ctDNA and ISET CTC-DNA improves tumor heterogeneity analysis and diagnostic accuracy
Analysis shows potential for patient benefits to extend far beyond obesity, opening doors to a new era of multi-disease prevention and care
Multiplex autoantibody test for MPO, PR3, and GBM designed to accelerate diagnosis of autoimmune vasculitis and Goodpasture’s disease
This partnership aims to redefine nucleic acid quantification and purification by leveraging liquid handling automation
Radiometer’s blood gas and immunoassay POC analysers deliver critical parameters enabling critical care teams to make quick decisions fast
Highly complementary technologies strengthen Thermo Fisher’s portfolio in bioprocessing and adjacent markets
Facility designed to advance the next generation of imaging systems
Collaboration leverages advanced simulation and regulatory expertise to develop decision frameworks for interim overall survival analysis in oncology clinical trials
MaxCyte’s Flow Electroporation technology and ExPERT platform to support the development of Adicet’s gamma delta T cell therapy gene edited programs
The initiative aims to identify and support new ideas for innovative oral formulations for peptide drugs such as GLP-1 receptor agonists
Combining Syncell’s Microscoop technology and Thermo Fisher’s Orbitrap Astral mass spectrometer series
Project is led by the Max-Planck Institute of Molecular Plant Physiology and also includes academics from University of Essex and UC Berkeley
This discovery can offer chocolate producers a powerful tool to craft consistently high-quality, flavor-rich chocolate
'Scripting Possibilities' to power the future of biotechnology
Secure your ticket to visit the biggest lab industry trade show in the UK
Cleanroom microbiology expert, Cherwell, to become AnalytiChem UK Ltd from 1st September 2025
Understaffing in the lab threatens the collaboration doctors depend on
46 companies and organizations were honored for supporting the association through advertising, sponsorships, and exhibits
First-of-its-kind study at ADLM 2025 lays the foundation for addressing public health threat
New findings at ADLM 2025 could remedy this failure
Dr. Stanley F. Lo, DABCC, FADLM, has been elected to serve on the ADLM board of directors as president-elect starting in August 2025
The award recognises Gradientech’s impactful and innovative campaign to raise awareness about its QuickMIC ultra-rapid antibiotic susceptibility testing (AST) system
With a bold new identity and expanded capabilities, HiArc emerges as a next-generation engineering and manufacturing partner for the life science and diagnostics industry
ADLM 2025 studies highlight promising options for cervical and endometrial cancer
Forging a powerful partnership to accelerate global healthcare innovation and dominate the emerging AI-driven clinical decision support market